NEXT GENERATION DIGITAL HEALTH
Industry-ready, DISTRIBUTED LEDGER TECH (DLT)-based platform
for high-quality, compliant
health care data management
Designed by Swiss life science, banking, and data privacy know-how
Centred around the individual, considered key element to Digital Health
Take down intra- and interorganisational barriers to realize effective product/service development and delivery
Ultra-innovative Distributed Ledger Technology (DLT) for required data security and quality
The life science continuum experiences growing challenges around digitalization (data acquisition, management, usage)
It spans regulatory, privacy, quality, and cyber security aspects
The industry’s fragmentation furthermore leads to stagnation and exploding care costs
Citizen centric & controlled
Data self-curation, Subsidiarity Curation™
Post-quantum computer safe, Cellular-Protective Data Structure™
Global cross-organizational compliance management
OOTB transaction handling at industrial scale
Patients – receive more effective treatments
Individuals – stay healthy by personalized prevention
Care industry – reengineer/improve data-driven service delivery processes
Pharma industry – improve R&D, product efficacy, and compliance
Society/Public – reduce health care costs
ONEBIO Digital Medical Ledger Platform (ODML)
Proprietary, industry-grade Distributed Ledger Technology
- no heavy additional investment needs for preparing classic blockchain distributions
- no limitations on block and file size, industry-ready transaction processing, ultra secure
Decentralized SPOHD platform (Single Point of Medical Data),
- patented built-in subsidiarity principle for data self-curation
- continuously truthful data for fuelling data-driven health care processes
Dynamic regulatory compliance
- patented built-in compliance engine for cross-organisational data portability
- no outbound tokenization, no attached financial regulatory risk
E2E data protection
- from Edge to Analytics, proprietary next-generation quantum-compute safe low-footprint tech
- native on-chain/off-chain transaction security through Cellular-Protective Data Structure
- E2E verification and regulation-compliant authentication
- cloud-native (SaaS), built for global scale, big data and AI
Our data management apps
Mobile – Citizen (Patient) Data Portfolio
Tablet – Care taker Management Dashboard
Web – Care taker Management Dashboard
Industrial engineer with extensive experience in healthcare, pharma, IT software industries, innovation management, industrialization, automation and building a Digital Ledger startup.
Sascha Sandi / COO
Serial Entrepreneur / Expert in IT infrastructure & Hosting.
Bioanalytical Analyst, Chief Laboratory.
Serial Entrepreneur / Expert in IT infrastructure & Hosting. Lecturer for computer science.
Experienced, multi-industry Strategy, Marketing and Sales Advisors | Former Top-Tier Strategy Consultant.
Get in touch
Disclaimer & Confidentiality
This document and the information contained in this document is strictly confidential. This document contains information that is proprietary to ONEBIO AG (ONEBIO) and its affiliates. You agree to not disclose this document or any of the information contained therein to any third party without the express prior consent of ONEBIO. Any distribution or dissemination of this document or the information contained therein without express permission of ONEBIO is strictly prohibited. This document and the information contained in this document may only be used by you to consider a business relationship with ONEBIO. Any other use of this document or the information contained therein without the express permission of ONEBIO is strictly prohibited. This document contains forward-looking statements, which include statements related to future business or financial performance, future events or future developments. In addition, representatives of ONEBIO may from time to time make oral forward-looking statements. Such statements are based on the current expectations, projections, estimates and assumptions of ONEBIO‘s management. Such statements are subject to a number of risks, uncertainties and factors, which could cause actual results to differ materially from those anticipated. Such statements are beyond ONEBIO’s control but are based on ONEBIO management’s beliefs, as well as on assumptions made by and information available to management at the time of preparation of this document and involve significant subjective judgments. Actual results, performance or achievements may differ materially from these expectations, projections, estimates or assumptions. Accordingly, no representations are made as to their attainability. ONEBIO neither intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated. Except where otherwise indicated, this document speaks only as the date hereof.